Bank of New York Mellon Corp - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 230 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$14,284,047
+2.4%
1,087,066
-1.8%
0.00%0.0%
Q2 2023$13,950,392
-6.6%
1,107,174
-3.2%
0.00%0.0%
Q1 2023$14,931,837
-29.3%
1,144,202
-4.5%
0.00%
-40.0%
Q4 2022$21,127,162
+5.0%
1,197,685
-9.3%
0.01%0.0%
Q3 2022$20,121,000
+6.9%
1,321,136
+4.1%
0.01%
+25.0%
Q2 2022$18,829,000
-36.8%
1,269,673
-4.1%
0.00%
-33.3%
Q1 2022$29,803,000
+25.8%
1,323,414
+3.1%
0.01%
+50.0%
Q4 2021$23,695,000
+29.5%
1,284,204
-6.2%
0.00%0.0%
Q3 2021$18,297,000
-33.9%
1,368,470
-8.5%
0.00%
-20.0%
Q2 2021$27,691,000
+15.9%
1,496,022
-6.0%
0.01%0.0%
Q1 2021$23,898,000
-3.0%
1,591,588
-6.7%
0.01%0.0%
Q4 2020$24,632,000
+67.7%
1,705,870
-5.5%
0.01%
+25.0%
Q3 2020$14,688,000
+17.4%
1,804,389
-2.3%
0.00%
+33.3%
Q2 2020$12,507,000
-0.5%
1,847,626
+3.5%
0.00%
-25.0%
Q1 2020$12,564,000
-36.6%
1,784,519
-11.6%
0.00%
-20.0%
Q4 2019$19,823,000
-10.7%
2,019,649
-0.1%
0.01%
-16.7%
Q3 2019$22,204,000
-14.8%
2,022,276
-9.7%
0.01%
-14.3%
Q2 2019$26,053,000
+25.5%
2,239,995
+2.9%
0.01%
+16.7%
Q1 2019$20,758,000
-6.6%
2,175,836
-5.6%
0.01%
-14.3%
Q4 2018$22,215,000
-33.0%
2,304,552
-1.0%
0.01%
-22.2%
Q3 2018$33,160,000
+14.7%
2,326,933
-3.4%
0.01%
+12.5%
Q2 2018$28,909,000
-10.1%
2,409,113
-7.5%
0.01%
-11.1%
Q1 2018$32,171,000
-16.3%
2,604,903
-1.4%
0.01%
-10.0%
Q4 2017$38,457,000
-24.9%
2,643,176
-26.5%
0.01%
-28.6%
Q3 2017$51,184,000
-10.8%
3,596,920
-20.0%
0.01%
-12.5%
Q2 2017$57,359,000
+7.9%
4,495,169
+7.2%
0.02%
+6.7%
Q1 2017$53,165,000
+39.1%
4,192,875
+12.0%
0.02%
+36.4%
Q4 2016$38,215,000
-34.6%
3,743,009
-15.7%
0.01%
-35.3%
Q3 2016$58,446,000
-8.1%
4,437,689
-11.4%
0.02%
-10.5%
Q2 2016$63,593,000
+68.1%
5,007,096
+74.8%
0.02%
+72.7%
Q1 2016$37,838,000
+16.2%
2,864,403
+35.2%
0.01%
+10.0%
Q4 2015$32,574,000
+15.9%
2,118,021
-6.6%
0.01%
+11.1%
Q3 2015$28,114,000
+1.0%
2,267,236
+11.5%
0.01%
+12.5%
Q2 2015$27,825,000
+18.8%
2,034,013
+3.9%
0.01%
+33.3%
Q1 2015$23,421,000
+0.2%
1,958,278
+7.0%
0.01%0.0%
Q4 2014$23,377,000
-8.2%
1,830,651
-3.6%
0.01%
-14.3%
Q3 2014$25,477,000
-57.3%
1,899,230
-48.9%
0.01%
-12.5%
Q2 2014$59,708,000
-24.5%
3,720,040
-15.2%
0.01%
-63.6%
Q1 2014$79,101,000
+17.7%
4,387,133
+0.9%
0.02%
+15.8%
Q4 2013$67,191,000
-50.8%
4,346,098
-52.7%
0.02%
-9.5%
Q3 2013$136,680,000
+135.0%
9,191,640
+104.5%
0.02%
+16.7%
Q2 2013$58,164,0004,494,9580.02%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q1 2015
NameSharesValueWeighting ↓
Kent Lake Capital LLC 925,000$12,154,5004.67%
EVR Research LP 1,289,037$16,937,9464.48%
Tamarack Advisers, LP 435,000$5,715,9003.70%
KESTREL INVESTMENT MANAGEMENT CORP 263,900$3,4682.19%
Tamarack Advisers, LP 200,000$2,628,0001.70%
Numerai GP LLC 274,319$3,604,5521.20%
Smith, Graham & Co., Investment Advisors, LP 525,915$6,910,5230.86%
PEREGRINE CAPITAL MANAGEMENT LLC 585,254$7,690,2380.23%
WESTFIELD CAPITAL MANAGEMENT CO LP 2,401,754$31,559,0480.22%
FULLER & THALER ASSET MANAGEMENT, INC. 2,543,242$33,418,1940.19%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders